01 / Summary
Overview
A concise product-specific introduction followed by the essential catalog profile.
Tirzepatide is a dual GIP and GLP-1 receptor agonist investigated in preclinical studies of glycemic regulation and changes in fat mass.
- Category
- Weight Loss & Metabolism
- Presentation
- Lyophilized powder
- Catalog strength
- 30 mg



